Cyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement
Tweet Send to a Friend
Cyclacel Pharma (NASDAQ: CYCC) disclosed the following on Thursday:Item 1.01. Entry Into a Material Definitive Agreement.On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
